Senores Pharmaceuticals Limited has informed the Exchange regarding a Media release dated May 15, 2025 in relation to the Audited Standalone and Consolidated financial results of the Company for the quarter and financial year ended March 31, 2025.
Senores Pharmaceuticals Limited has informed the Exchange regarding a Media release dated May 15, 2025 in relation to the Audited Standalone and Consolidated financial results of the Company for the quarter and financial year ended March 31, 2025.